This inventor holds 1 USPTO granted patent. Top assignee: Lexicon Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations of Bruno Burel in Pharmaceutical Chemistry
Introduction
Bruno Burel is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug formulation. His work is characterized by a focus on innovative methods that enhance the efficiency and effectiveness of pharmaceutical compounds.
Latest Patents
Bruno Burel holds a patent for a continuous process for preparing the crystalline form II of sotagliflozin. This patent outlines a method that involves several key steps, including the reaction of a specific compound in a solvent, followed by crystallization in a non-aqueous medium. The process is designed to isolate the crystalline form II of sotagliflozin, which is crucial for its pharmaceutical applications. He has 1 patent to his name.
Career Highlights
Bruno Burel is currently associated with Lexicon Pharmaceuticals, Inc., where he applies his expertise in pharmaceutical development. His innovative approach to drug formulation has positioned him as a valuable asset in the industry. His work not only contributes to the advancement of pharmaceutical sciences but also enhances the therapeutic potential of new medications.
Collaborations
Bruno has collaborated with several professionals in his field, including Jérome Cezerac and Stéphane Dutheil. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their shared projects.
Conclusion
Bruno Burel's contributions to pharmaceutical chemistry exemplify the importance of innovation in drug development. His patent for the continuous process of preparing sotagliflozin highlights his commitment to enhancing pharmaceutical formulations. His work continues to influence the industry positively.